Cargando…
Perceptions of French general practitioners and patients regarding dextropropoxyphene withdrawal: a qualitative study
OBJECTIVES: Dextropropoxyphene (DXP), a step 2 analgesic commonly prescribed in France, was withdrawn from the French market in 2011 following a European decision due to its poor risk-benefit ratio. The purpose of this study was to explore the perceptions of French general practitioners (GPs) and pa...
Autores principales: | Combier, Aurélie, Bon, Lucile, Van Ganse, Eric, Aubrun, Frédéric, Letrilliart, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157533/ https://www.ncbi.nlm.nih.gov/pubmed/30244207 http://dx.doi.org/10.1136/bmjopen-2018-021582 |
Ejemplares similares
-
Use of analgesics in France, following dextropropoxyphene withdrawal
por: Van Ganse, E., et al.
Publicado: (2018) -
Ban on Dextropropoxyphene is Unjustifiable
por: Butola, Savita, et al.
Publicado: (2015) -
Survival after an overdose of Distalgesic (dextropropoxyphene and paracetamol).
por: Ruane, B. J., et al.
Publicado: (1989) -
Dextropropoxyphene ban in India: Is there a case for reconsideration?
por: Balhara, Yatan Pal Singh
Publicado: (2014) -
General practitioner gender and use of diagnostic procedures: a French cross-sectional study in training practices
por: Bouissiere, Amandine, et al.
Publicado: (2022)